ALEKSANDRA PETERSON: Open Payments
NPI 1689217804 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 135 payments from 18 companies in 2025. Trend: 2023 $1,696 · 2024 $3,158 · 2025 $2,262
Food & beverage: $2,209Education: $53
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $594 |
| GENZYME CORPORATION | 12 | $350 |
| Lilly USA, LLC | 18 | $241 |
| Incyte Corporation | 11 | $192 |
| Novartis Pharmaceuticals Corporation | 10 | $189 |
| Regeneron Healthcare Solutions, Inc. | 10 | $147 |
| Amgen Inc. | 6 | $104 |
| UCB, Inc. | 5 | $101 |
| Botanix SB Inc | 3 | $53 |
| Galderma Laboratories, L.P. | 3 | $48 |
Products named: SKYRIZI, DUPIXENT, OPZELURA, EBGLYSS, RINVOQ, Otezla, Bimzelx, TALTZ.
Industry payments across NJ — which companies pay providers there.
